Search Results for: stem cells for ms

South Africa grapples with “illegal” stem cell experiment scandal

/
Dr.-Wian-Stander

South Africa is facing a stem cell scandal related to what a health policy news outlet called Spotlight there characterizes as illegal experiments by ReGenesis Biotechnologies, the company at the heart of the controversy. It had a contract with a governmental health provider agency, now apparently suspended. The report begins this way: “The Medicines Control Council […]

South Africa grapples with “illegal” stem cell experiment scandal Read More »

No radical life extension, says Nature paper, but Russian gets stem cell infusion to go for it

/ / 9 Comments
Jeanne-Calment-

Any takers on the idea that we can get radical life extension through new technologies like stem cells, organ replacement, cybernetics, or genetic modification? Or just through healthier living in general? A new Nature paper says there’s a natural limit on human lifespan around age 115 and getting past that is just not going to

No radical life extension, says Nature paper, but Russian gets stem cell infusion to go for it Read More »

Where does stem cell business Stemedica go from here after KPBS investigative report?

/ / 9 Comments
stemedica

For quite a while there San Diego-based stem cell business Stemedica had a good run of publicity with reports of high-profile professional sports legends getting stem cells and the media reporting apparent good outcomes for stroke recovery, but more recent times have yielded some different publicity. An investigative report by KPBS reporter David Wagner raised some

Where does stem cell business Stemedica go from here after KPBS investigative report? Read More »

4,000+ comments on FDA stem cell guidances, mostly clones of “My cells are my cells”

/ / 4 Comments
FDA-stem-cell-comments-e1475354119256

Keep your hands off of my cells! At least, that is what many are telling the FDA regarding stem cells. The FDA issued four draft guidances related to stem cells in the past year or so, held two public stem cell meetings, and now must decide what it is going to do with an out

4,000+ comments on FDA stem cell guidances, mostly clones of “My cells are my cells” Read More »

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD

/ / 6 Comments
Cynata

Cynata Therapeutics Limited has received approval from UK regulators to start a first-of-its-kind allogeneic IPSC-based trial of MSCs for graft versus host disease (GVHD). Cynata also had some big news a couple weeks back with a deal with Fujifilm. The company is aiming to recruit 16 patients to test whether the MSCs (a type of adult

Cynata approval for 1st ever allo trial of IPSC-derived MSCs for GVHD Read More »

KPBS sheds new light on Jim Gass stem cell case, Stemedica

/ / 29 Comments
Cesar-Anescua-Jim-Gass

KPBS reporter David Wagner has an important new piece out today on for-profit investigational stem cell treatments and he focuses to a large extent on a stem cell business in San Diego called Stemedica. If you’ve heard of this company it might be in part because they were involved in the Gordie Howe stem cells for stroke story that got

KPBS sheds new light on Jim Gass stem cell case, Stemedica Read More »

What happens next with FDA & stem cells: lower your expectations?

/ / 4 Comments
FDA

In the total the FDA has held 3 days of public meetings on stem cells in the last few weeks ranging from science to policy and hearing from many parties including patients and even stem cell clinics so the big question now is, “what happens next?” The FDA has 4 draft guidances pertaining to investigational

What happens next with FDA & stem cells: lower your expectations? Read More »

Early, but encouraging data from Asterias on stem cells for spinal cord injury

/
Asterias

As I posted recently, Asterias Biotherapeutics has had good early safety results so far in its historic stem cell trial for spinal cord injury and now the company presented some early, encouraging hints at efficacy.  However, a caveat here is that this is not an RCT (randomized controlled trial). Ed Wirth, CMO of Asterias, presented the

Early, but encouraging data from Asterias on stem cells for spinal cord injury Read More »

Jeanne Loring’s Report from Inside FDA Stem Cell Meeting Day 1

/ / 10 Comments
Loring-in-lab-1

By Jeanne Loring Paul did a good job of giving an overview of the FDA meeting today. Being in the room, I have a few observations that complement Paul’s. I’ve never been to a meeting like this- there were 42 scheduled 5 minute presentations, and this is just the first of 2 days. The question

Jeanne Loring’s Report from Inside FDA Stem Cell Meeting Day 1 Read More »